{"nct_id":"NCT02315703","title":"Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2014-12-22","start_date_type":"ACTUAL","primary_completion_date":"2017-08-29","primary_completion_date_type":"ACTUAL","completion_date":"2022-03-28","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["JNJ"]}